NIH-funded research R01 grant

Understanding how certain proteins regulate brain receptor activity

Official title: Regulation of metabotropic glutamate receptor activity by protein/protein interactions

Funded at Vanderbilt University · NIH-11047804 · Data updated 2026-11-12

This study is looking at how certain proteins affect brain receptors that help control communication between nerve cells, with the goal of finding better treatments for people with ADHD and autism by understanding how these proteins work and how genetic changes might influence them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startDecember 1, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$396,250
NIH project number1R01MH136164-01A1
Project IDNIH-11047804 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with ADHD, autism spectrum disorder, or related cognitive impairments.

Less likely to help

Patients with conditions unrelated to neurotransmitter regulation or those without cognitive impairments may not benefit from this research.

What this research studies

This research investigates the role of metabotropic glutamate receptors, which are important for controlling neurotransmitter release in the brain. It focuses on how specific proteins interact with these receptors to influence their location and function, particularly in relation to conditions like ADHD and autism. By studying these interactions, the research aims to uncover mechanisms that could lead to better treatments for cognitive and motor impairments associated with these disorders. The approach includes examining genetic mutations and their effects on receptor behavior in both human and animal models.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing ADHD, autism, and related cognitive disorders.

How similar studies have gone: Previous research has shown promising results in understanding receptor interactions and their implications for neurological disorders, indicating that this approach has potential for success.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Niswender, Colleen M — Vanderbilt University
  • Study coordinator: Niswender, Colleen M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.